Add your comment below for Resolution #5
Comments Submitted by Most Recent-Updated by MSMA
Writing on behalf of the authors and MSMA Medical Student Section Board, in strong support of this resolution. Over the past decade, the cost of the four most popular insulin types has tripled. From 2012 to 2016, the cost has nearly doubled to an average of $450 per month, far outpacing general inflation. These increases in costs lead to nearly a quarter of people with diabetes to not take their insulin as recommended by their physician. I do not have to tell you how dangerous this is to patients. Not only does it lead to immediate harms, poor glycemic control has many downstream effects leading to immense costs on our health care system. Drug pricing is currently a hot button issue in Washington, and Colorado and Illinois have recently passed legislation limiting the out-of-pocket costs of insulin to $100 per month. The American Diabetes Association has been supportive of these legislative efforts. Additionally, The Endocrine Society has called for major policy changes to address this growing issue, going so far as to recommend providing human insulin to patients at no cost. During the creation of this resolution, The Endocrine Society was consulted and they supported this resolution. While the asks in our resolve clause do not address the underlying problem with increasing drug prices, we believe this is a reasonable and actionable step, we as a medical society can take to advocate on behalf of our patients. Thank you.
-Alex Shimony, Representing MSMA-MSS Board
As emergency physician I saw too many people in DKA due to the fact that they could not afford your insulin. I fully support this resolution.
-Rebecca Hierholzer, MD, Representing self
I fully support this resolution.
-Sri Kolli, MD, Representing self